347MO The safety and efficacy of ivonescimab in combination with chemotherapy as first-line (1L) treatment for triple-negative breast cancer (TNBC)

Qi Ouyang, Xishan Wang, Chuan Tian, Xuan Shao, Jia Huang, ZH Chen, Y. wang, Tao Sun, T. Yi, Xingfei Yu, Zhongmin Wang, Bin Li, Yi Xia